Connect with:
Friday / October 7. 2022

Login/Logout Subscribe Newsletter E-Magazine

HomeAgrotechICL join hands with PlantArcBio to boost canola crop yields

ICL join hands with PlantArcBio to boost canola crop yields

source-public domain

Field trials have resulted in significant improvement, while leaving minimal footprint.

Israel based leading global specialty minerals company, and ag-biotech company PlantArcBio, Ltd. has announced the development of a novel bio-stimulant technology platform, which will improve crop yields while having minimal impact on the environment.  The platform successfully uses of RNAi technology to maximize a plant’s natural yield increase mechanisms, without any genetic modification, and was the result of a multi-year research collaboration between the two companies.

In early-stage canola field trials, the platform has significantly increased seed weight per hectare for canola crops, and ICL and PlantArcBio are planning larger-scale field trials in 2022.  These will include testing the new technology platform using both commercial sprayers and standard farming practices.  Greenhouse trials for soybeans and rice are already in progress, with early results showing good potential. 

“The use of novel biostimulants based on RNAi technology helps promote sustainability, by reducing the use of chemicals in agriculture,” explained Hadar Sutovsky, vice president of External Innovation and general manager of ICL Planet. “This aligns perfectly with ICL’s long-term goal of creating impact and sustainable growth in the agriculture end-market, alongside ensuring food security.” 

“ICL and PlantArcBio have filed for a joint patent on the application for multiple crops,” said Sutovsky. “The application does its work, then rapidly disappears from both the plants and the environment, lasting no more than a few days, as it is highly biodegradable and also leaves no residual footprint.”

“The positive canola field trial results constitute another milestone in strengthening PlantArcBio’s capabilities in the development of RNAi-based products,” said Dror Shalitin, Ph.D., founder and CEO of PlantArcBio. 

No comments

leave a comment